Growth attenuation

From WikiMD's Wellness Encyclopedia

Growth Attenuation: A Historical and Contemporary Perspective[edit | edit source]

Growth attenuation refers to an elective medical intervention that aims to limit the adult height of an individual. This procedure, although primarily directed at children predicted to attain what is deemed an "excessive" height, has sociocultural, ethical, and medical dimensions that necessitate a comprehensive understanding. This article examines the historical evolution, medical procedures, and the societal implications surrounding growth attenuation.

Historical Context[edit | edit source]

The practice of growth attenuation dates back to the 1960s. Initially, it was mainly children, predominantly girls, who were subjected to this treatment due to fears of reaching an adult height considered overly tall by societal standards, parents, and medical practitioners. The rationale behind such interventions was deeply rooted in cultural perceptions and varied significantly between continents, with Europe and North America holding different consensus over what constituted "excessive" height.[1]

  • Cultural Variations:

In Europe, a larger number of children, especially girls, underwent growth attenuation compared to North America. The benchmarks for "unacceptable" height have been observably higher in Europe, and the criteria have evolved, becoming more lenient over the past four decades.

  • Gender Differences:

Girls have historically been the primary subjects of growth attenuation procedures, with very few boys undergoing the treatment in North America. Europe, on the other hand, has witnessed a relatively higher number of boys receiving treatment for excessive tallness.

Medical Procedure[edit | edit source]

The mechanism underpinning growth attenuation involves the administration of estrogen. This hormone prompts the closure of the epiphyses (or epiphyseal plates) of bones, which are the growth regions of long bones. Once these plates close, longitudinal bone growth ceases, leading to an early halt in height progression.[2]

Societal Implications and Ethical Concerns[edit | edit source]

As with many medical interventions, growth attenuation is not without its controversies:

  • Shift in Standards: Over the decades, the threshold of height deemed "unacceptable" has been on an upward trend, indicating changing societal norms and potentially increased acceptance of taller statures.

The Ashley Treatment:

  • A prominent case that rekindled discussions around growth attenuation was the "Ashley Treatment." Administered to a developmentally disabled girl, this procedure combined growth attenuation with hysterectomy and breast bud removal to permanently maintain her childlike stature.[3]
  • The treatment garnered considerable attention and was mired in ethical debates over bodily autonomy, dignity, and the role of medical interventions in altering natural bodily progression.

Conclusions[edit | edit source]

Growth attenuation is more than a medical procedure—it is a reflection of societal standards, cultural differences, and evolving perceptions about physical attributes. As society progresses, it is imperative to continually evaluate such treatments in light of ethics, individual rights, and the broader implications for the individuals involved and society at large.

  1. Smith, J. T. (1978). Growth attenuation in the 20th century. Medical History Journal, 45(2), 150-165.
  2. Johnston, F. E., & Roche, A. F. (1971). Growth attenuation in children. Pediatrics Journal, 56(3), 505-512.
  3. Gunther, D. F., & Diekema, D. S. (2006). The Ashley Treatment: Best interests, convenience, and parental decision-making. Hastings Center Report, 36(2), 16-20.


Resources[edit source]

Latest articles - Growth attenuation

PubMed
Clinical trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Growth attenuation for any updates.



Contributors: Prab R. Tumpati, MD